SG11201610630RA - Identification of cancer stem cell markers and use of same for diagnosis and treatment - Google Patents
Identification of cancer stem cell markers and use of same for diagnosis and treatmentInfo
- Publication number
- SG11201610630RA SG11201610630RA SG11201610630RA SG11201610630RA SG11201610630RA SG 11201610630R A SG11201610630R A SG 11201610630RA SG 11201610630R A SG11201610630R A SG 11201610630RA SG 11201610630R A SG11201610630R A SG 11201610630RA SG 11201610630R A SG11201610630R A SG 11201610630RA
- Authority
- SG
- Singapore
- Prior art keywords
- diagnosis
- identification
- treatment
- same
- stem cell
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90203—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462016773P | 2014-06-25 | 2014-06-25 | |
| PCT/IL2015/050663 WO2015198334A2 (fr) | 2014-06-25 | 2015-06-25 | Identification de cellules souches cancéreuses et utilisation de celles-ci pour des diagnostics et traitements |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201610630RA true SG11201610630RA (en) | 2017-01-27 |
Family
ID=53674236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201610630RA SG11201610630RA (en) | 2014-06-25 | 2015-06-25 | Identification of cancer stem cell markers and use of same for diagnosis and treatment |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10883994B2 (fr) |
| EP (1) | EP3161480B1 (fr) |
| JP (1) | JP6587288B2 (fr) |
| KR (1) | KR20170041192A (fr) |
| CN (1) | CN106537148B (fr) |
| AU (1) | AU2015278659A1 (fr) |
| CA (1) | CA2953663A1 (fr) |
| ES (1) | ES2791199T3 (fr) |
| IL (1) | IL249741B (fr) |
| SG (1) | SG11201610630RA (fr) |
| WO (1) | WO2015198334A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2953663A1 (fr) | 2014-06-25 | 2015-12-30 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Identification de cellules souches cancereuses et utilisation de celles-ci pour des diagnostics et traitements |
| EP3427059A1 (fr) | 2016-03-09 | 2019-01-16 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Fer cellulaire total utilisé comme marqueur de cellules souches cancéreuses et ses utilisations |
| CN108967358A (zh) * | 2018-05-31 | 2018-12-11 | 上海交通大学医学院附属瑞金医院 | 一种斑马鱼fl肿瘤模型的构建方法及其应用 |
| KR20200109544A (ko) * | 2019-03-13 | 2020-09-23 | 울산대학교 산학협력단 | 공통 유전자 추출에 의한 다중 암 분류 방법 |
| KR102400464B1 (ko) * | 2020-07-28 | 2022-05-19 | 부산대학교 산학협력단 | 암 줄기세포 검출용 바이오 마커 조성물 |
| CN114624304B (zh) * | 2021-12-09 | 2023-09-19 | 重庆医科大学国际体外诊断研究院 | 基于铈银纳米花和分支DNAzyme步行器的miRNA电化学传感器 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4289747A (en) | 1978-12-26 | 1981-09-15 | E-Y Laboratories, Inc. | Immunological determination using lectin |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5204096A (en) | 1984-03-07 | 1993-04-20 | New York Blood Center, Inc. | Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5171578A (en) | 1985-06-26 | 1992-12-15 | The Liposome Company, Inc. | Composition for targeting, storing and loading of liposomes |
| US5258499A (en) | 1988-05-16 | 1993-11-02 | Vestar, Inc. | Liposome targeting using receptor specific ligands |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| US6132764A (en) | 1994-08-05 | 2000-10-17 | Targesome, Inc. | Targeted polymerized liposome diagnostic and treatment agents |
| US5935850A (en) | 1996-09-30 | 1999-08-10 | The Research Foundation Of State University Of New York | Model for cell migration and use thereof |
| US6037137A (en) | 1997-02-20 | 2000-03-14 | Oncoimmunin, Inc. | Fluorogenic peptides for the detection of protease activity |
| US6984522B2 (en) | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
| TW200422749A (en) | 2003-04-22 | 2004-11-01 | Adv Lcd Tech Dev Ct Co Ltd | Crystallization apparatus, crystallization method, phase modulation element, device and display apparatus |
| US20070021365A1 (en) * | 2005-06-21 | 2007-01-25 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of Lysyl oxidase for treating tumor growth and diagnostics relating thereto |
| AU2008207945A1 (en) * | 2007-01-22 | 2008-07-31 | Macrogenics West, Inc. | Human cancer stem cells |
| EP2022848A1 (fr) * | 2007-08-10 | 2009-02-11 | Hubrecht Institut | Procédé d'identification, d'expansion, et de suppression de cellules souches adultes et cellules souches de cancer |
| US10029956B2 (en) * | 2008-03-14 | 2018-07-24 | Retrotope, Inc. | Therapies for cancer using isotopically substituted lysine |
| WO2009120100A1 (fr) | 2008-03-26 | 2009-10-01 | Veritide Limited | Système d'analyse |
| WO2010009121A2 (fr) * | 2008-07-15 | 2010-01-21 | University Of Florida Research Foundation, Inc. | Cellules souches de côlon associées à la colite et au cancer colorectal et procédés d’utilisation |
| EP2401362B1 (fr) | 2009-02-26 | 2017-04-12 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation |
| WO2010110346A1 (fr) * | 2009-03-24 | 2010-09-30 | 独立行政法人理化学研究所 | Marqueurs de cellules souches leucémiques |
| EP2611463A2 (fr) | 2010-09-03 | 2013-07-10 | Stem Centrx, Inc. | Identification et enrichissement de populations de cellules |
| EP3603671A3 (fr) * | 2011-10-28 | 2020-07-29 | Chugai Seiyaku Kabushiki Kaisha | Molécule spécifique de cellules souches du cancer |
| CA2953663A1 (fr) | 2014-06-25 | 2015-12-30 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Identification de cellules souches cancereuses et utilisation de celles-ci pour des diagnostics et traitements |
-
2015
- 2015-06-25 CA CA2953663A patent/CA2953663A1/fr not_active Abandoned
- 2015-06-25 EP EP15739030.3A patent/EP3161480B1/fr active Active
- 2015-06-25 WO PCT/IL2015/050663 patent/WO2015198334A2/fr active Application Filing
- 2015-06-25 AU AU2015278659A patent/AU2015278659A1/en not_active Abandoned
- 2015-06-25 KR KR1020177001924A patent/KR20170041192A/ko unknown
- 2015-06-25 US US15/320,847 patent/US10883994B2/en active Active
- 2015-06-25 SG SG11201610630RA patent/SG11201610630RA/en unknown
- 2015-06-25 CN CN201580037960.8A patent/CN106537148B/zh active Active
- 2015-06-25 JP JP2016574232A patent/JP6587288B2/ja not_active Expired - Fee Related
- 2015-06-25 ES ES15739030T patent/ES2791199T3/es active Active
-
2016
- 2016-12-22 IL IL249741A patent/IL249741B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170041192A (ko) | 2017-04-14 |
| EP3161480A2 (fr) | 2017-05-03 |
| EP3161480B1 (fr) | 2020-02-12 |
| CN106537148B (zh) | 2019-10-11 |
| JP6587288B2 (ja) | 2019-10-09 |
| US10883994B2 (en) | 2021-01-05 |
| WO2015198334A2 (fr) | 2015-12-30 |
| IL249741B (en) | 2019-12-31 |
| ES2791199T3 (es) | 2020-11-03 |
| IL249741A0 (en) | 2017-02-28 |
| JP2017528114A (ja) | 2017-09-28 |
| AU2015278659A1 (en) | 2017-02-02 |
| US20170199195A1 (en) | 2017-07-13 |
| CN106537148A (zh) | 2017-03-22 |
| CA2953663A1 (fr) | 2015-12-30 |
| WO2015198334A3 (fr) | 2016-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1253093A1 (zh) | 診斷和治療癌症的方法 | |
| ZA201607415B (en) | Antibody-drug-conjugate and its use for the treatment of cancer | |
| IL252766B (en) | Use of markers including filamin a in the diagnosis and treatment of prostate cancer | |
| EP3071131A4 (fr) | Ensemble orifice d'accès chirurgical de type adaptateur et procédés d'utilisation | |
| HK1245401A1 (zh) | 鑑定、選擇和使用高治療潛力的t細胞表位 | |
| HRP20190888T8 (hr) | Konjugat antitijela za igf-1r i lijeka i njegova upotreba u liječenju karcinoma | |
| IL253160B (en) | Cancer markers and methods of using them | |
| IL249741B (en) | Identification of cancer stem cell markers and their use for detection and treatment | |
| SG11201700552SA (en) | Precision chemical ablation and treatment of tissues | |
| HUE041700T2 (hu) | Hosszú, nem kódoló RNS-ek (IncRNS-ek) szívhipertrófia terápiájára és diagnosztizálására | |
| SG11201701035SA (en) | Cancer diagnosis and therapy | |
| GB201413357D0 (en) | Antibodies for treatment and diagnosis | |
| HK1243105A1 (zh) | 高活性的腫瘤抑制劑及其製法和應用 | |
| GB201409363D0 (en) | Skin cancer treatment | |
| HK1223983A1 (zh) | 用於脊柱側凸的分類、診斷和治療的新標記 | |
| HK1255691A1 (zh) | 對疾病進行組織學診斷和治療的方法 | |
| IL248473B (en) | Biomarkers to identify patients for treatment with abiraterone acetate | |
| IL251825B1 (en) | Treatment of cancer and skin damage | |
| HK1243734A1 (zh) | 頭頸部癌症的生物標誌物及其使用方法 | |
| AU2014903514A0 (en) | Markers of Disease Susceptibility and Onset and Uses Therefor | |
| GB201418640D0 (en) | Agents and methods for treatment of cancer | |
| GB201501202D0 (en) | Novel methods for diagnosis and therapy |